SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000897101-18-000644
Filing Date
2018-07-19
Accepted
2018-07-19 08:44:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G kiniksa181621_13g.htm SC 13G 64679
  Complete submission text file 0000897101-18-000644.txt   65922
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90491 | Film No.: 18959635
SIC: 2834 Pharmaceutical Preparations

Mailing Address 170 EAST 93RD ST. NEW YORK NY 10128
Business Address
Desnick Robert (Filed by) CIK: 0001745601 (see all company filings)

Type: SC 13G